Dual association of a TRKA polymorphism with schizophrenia

Psychiatric Genetics

Volumn 21, Issue 3, 2011, Pages 125-131

  Van Schijndel, Jessica E ^a   Van Zweeden, Martine ^a   Van Loo, Karen M J ^a   Djurovic, Srdjan ^b   Andreassen, Ole A ^b,c   Hansen, Thomas ^d   Werge, Thomas ^d   Nyegaard, Mette ^e,f,i   Sørensen, Karina Meden ^h   Nordentoft, Merete ⁱ   Mortensen, Preben B ^e   Mors, Ole ^g   Børglum, Anders D ^e,g   Del Favero, Jurgen ^k,l   Norrback, Karl Fredrik ^l,n,o   Adolfsson, Rolf ^n,o   Hert, Marc De ^m   Claes, Stephan ^m   Cichon, Sven ^p,q   Rietschel, Marcella ^r   Nöthen, Markus M ^p,q   Kallunki, Pekka ^j   Pedersen, Jan T ^j   Martens, Gerard J M ^a,s   more..

^a RADBOUD UNIVERSITY   (Netherlands)

^b UNIVERSITY OF OSLO   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d Copenhagen University Hospital ^*  (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h STATENS SERUM INSTITUT   (Denmark)

ⁱ UNIVERSITY OF COPENHAGEN   (Denmark)

^j H LUNDBECK A S   (Denmark)

^k DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^l UNIVERSITY OF ANTWERP   (Belgium)

^m UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

ⁿ UMEÅ UNIVERSITY   (Sweden)

^o Sunderby County Hospital   (Sweden)

^p UNIVERSITY OF BONN   (Germany)

^q FORSCHUNGSZENTRUM JÜLICH   (Germany)

^r CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^s RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

casecontrol study; meta analysis; neurotrophic tyrosine kinase receptor 1; protective factor; risk factor

Indexed keywords

PROTEIN TYROSINE KINASE A;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; EUROPE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TRKA; SCHIZOPHRENIA; UNITED STATES;

EID: 79955605758     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e3283437194     Document Type: Article

References (38)

1. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, et al. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 40:827-834. (Pubitemid 351913655)
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Publishing, Inc; Arlington: 1994.
3. Becker A, Grecksch G, Schwegler H, Roskoden T (2008). Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment. Med Chem 4:256-263. (Pubitemid 351827300)
4. Benzel I, Bansal A, Browning BL, Galwey NW, Maycox PR, McGinnis R, et al. (2007). Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 3:31.
5. Buckley PF, Mahadik S, Pillai A, Terry A Jr (2007). Neurotrophins and schizophrenia. Schizophr Res 94:1-11. (Pubitemid 47033973)
6. Cardno AG, Gottesman II (2000). Twin studies of schizophrenia: from bow-andarrow concordances to star wars Mx and functional genomics. Am J Med Genet 97:12-17. (Pubitemid 30257322)
7. Carter CJ (2006). Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res 86:1-14. (Pubitemid 44234053)
8. Chotai J, Serretti A, Lorenzi C (2005). Interaction between the tryptophan hydroxylase gene and the serotonin transporter gene in schizophrenia but not in bipolar or unipolar affective disorders. Neuropsychobiology 51:3-9. (Pubitemid 40867984)
9. Cucherat M, Boissel JP, Leizorovicz A, Haugh MC (1997). EasyMA: a program for the meta-analysis of clinical trials. Comput Methods Programs Biomed 53:187-190. (Pubitemid 27305437)
10. Ekholm B, Ekholm A, Adolfsson R, Vares M, Osby U, Sedvall GC, et al. (2005). Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry 59:457-464. (Pubitemid 41801793)
11. Farmer AE, Wessely S, Castle D, McGuffin P (1992). Methodological issues in using a polydiagnostic approach to define psychotic illness. Br J Psychiatry 161:824-830.
12. Gaebel W, Zielasek J (2008). The DSM-V initiative deconstructing psychosis in the context of Kraepelins concept on nosology. Eur Arch Psychiatry Clin Neurosci 258 (Suppl 2):41-47. (Pubitemid 351758760)
13. Gauderman WJ (2002). Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155:478-484. (Pubitemid 34174160)
14. Glatt SJ, Jonsson EG (2006). The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am J Med Genet B Neuropsychiatr Genet 141B:149-154. (Pubitemid 43214790)
15. Goghari VM, Sponheim SR (2008). Differential association of the COMT Val158Met polymorphism with clinical phenotypes in schizophrenia and bipolar disorder. Schizophr Res 103:186-191.
16. Jonsson EG, Edman-Ahlbom B, Sillen A, Gunnar A, Kulle B, Frigessi A, et al. (2006). Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 30:924-933. (Pubitemid 43810174)
17. Kong A, Steinthorsdottir V, Masson G, Thorleifsson G, Sulem P, Besenbacher S, et al. (2009). Parental origin of sequence variants associated with complex diseases. Nature 462:868-874.
18. Leckman JF, Sholomskas D, Thompson WD, Belanger A,Weissman MM (1982). Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 39:879-883. (Pubitemid 12042853)
19. Lencz T, Morgan TV, Athanasiou M, Dain B, Reed CR, Kane JM, et al. (2007). Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 12:572-580. (Pubitemid 46816774)
20. Lewis CM, Levinson DF,Wise LH, DeLisi LE, Straub RE, Hovatta I, et al. (2003). Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 73:34-48. (Pubitemid 36793778)
21. Lin PI, Vance JM, Pericak-Vance MA, Martin ER (2007). No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80:531-538.
22. Mardy S, Miura Y, Endo F, Matsuda I, Indo Y (2001). Congenital insensitivity to pain with anhidrosis (CIPA): effect of TRKA (NTRK1) missense mutations on autophosphorylation of the receptor tyrosine kinase for nerve growth factor. Hum Mol Genet 10:179-188. (Pubitemid 32123975)
23. Munafo MR, Bowes L, Clark TG, Flint J (2005). Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol Psychiatry 10:765-770. (Pubitemid 41129049)
24. Nilsson LG, Backman L, Erngrund K, Nyberg L, Adolfsson R, Bucht G, et al. (1997). The Betula prospective cohort study: memory, health and aging. Aging Neuropsychol Cognit 4:1-32. (Pubitemid 27245220)
25. Norgaard-Pedersen B, Hougaard DM (2007). Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis 30:530-536. (Pubitemid 47377048)
26. Norton N, Williams HJ, Dwyer S, Carroll L, Peirce T, Moskvina V, et al. (2007). Association analysis of AKT1 and schizophrenia in a UK case control sample. Schizophr Res 93:58-65. (Pubitemid 46817938)
27. ODonovan MC, Craddock N, Norton N, Williams H, Peirce T, Moskvina V, et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 40:1053-1055.
28. Parikh V, Evans DR, Khan MM, Mahadik SP (2003). Nerve growth factor in nevermedicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome. Schizophr Res 60: 117-123. (Pubitemid 36187455)
29. Quednow BB,Wagner M, Mossner R, Maier W, Kuhn KU (2008). Sensorimotor gating of schizophrenia patients depends on catechol O-methyltransferase Val158Met polymorphism. Schizophr Bull 36:341-346.
30. Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T, et al. (2008). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18:988-996.
31. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B, et al. (2005). Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiatry 58:446-450. (Pubitemid 41393606)
32. Shi J, Gershon ES, Liu C (2008). Genetic associations with schizophrenia: Meta-analyses of 12 candidate genes. Schizophr Res 104:96-107.
33. Shoval G,Weizman A (2005). The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol 15:319-329.
34. Spitzer RL, Williams JB, Gibbon M, First MB (1992). The structured clinical interview for DSM-III-R (SCID). I: history, rationale, and description. Arch Gen Psychiatry 49:624-629.
35. Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S, et al. (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455:232-236.
36. Terry AV, Gearhart DA, Pillai A, Zhang G, Bartlett MG (2010). Chronic antipsychotic treatment: protracted decreases in phospho- TrkA levels in the rat hippocampus. Int J Neuropsychopharmacol 13: 799-805.
37. Van Schijndel JE, Van Loo KM, Van Zweeden M, Djurovic S, Andreassen OA, Hansen T, et al. (2009). Three-cohort targeted gene screening reveals a nonsynonymous TRKA polymorphism associated with schizophrenia. J Psychiatr Res 43:1195-1199.
38. Weinberger DR (1995). From neuropathology to neurodevelopment. Lancet 346:552-557.